0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Terms of Engraftment: Umbilical Cord Blood Transplants Arouse Enthusiasm

Joan Stephenson, PhD
JAMA. 1995;273(23):1813-1815. doi:10.1001/jama.1995.03520470021007.
Text Size: A A A
Published online

ABSTRACT

AN EVER-GROWING number of transplants using blood harvested from the placenta and umbilical cord of newborn infants are pointing the way toward a new approach for treating cancer, serious blood disorders, and perhaps a range of other illnesses, from inherited diseases to AIDS.

The reason cord blood holds such promise is that it contains the same vital stem and progenitor hematopoietic cells found in bone marrow. These key cells, whether from marrow or cord blood, have the potential to "self-renew," or regenerate themselves, and to differentiate into the entire menagerie of blood cells required by the body.

However, there is increasing evidence that cord blood provides some distinct advantages, both logistic and biological, over bone marrow transplants. For example, cord blood can be obtained noninvasively at the time of delivery and stored for months or years, available on demand for later use—either by the donor, if he or she later

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();